Retinol binding protein‐4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women

Abstract

The results obtained in MO women with NAFLD, brings up the use of RBP4 and other adipokines as a panel of noninvasive molecular biomarkers when NAFLD is suspected. Further studies are needed with other obesity groups.